18 February 2016

Joint Position Statement by HAI, The Commons Network and Public Citizen.

Summary

Both the European Union (EU) and the United States (US) are confronted with increasingly high medicine prices. European Member States are facing a looming access to medicines crisis as they struggle to afford new, patented, high-priced medicines. The Transatlantic Trade and Investment Partnership Agreement (TTIP), now under negotiation, could hamper needed changes towards affordability, needs-driven innovation and alternative incentive structures.

> Click here to download the Position Statement (pdf, 59 Ko)